BiotechTube
Home/Anaveon/Christoph Huber
CH

Christoph Huber

Chief Scientific Officer

Anaveon

Therapeutic Areas

Autoimmune DiseasesInflammatory Diseases

Anaveon Pipeline

DrugIndicationPhase
ANV200Autoimmune DiseasesPreclinical

Leadership Team at Anaveon

TR
Thaminda Ramanayake
Chief Executive Officer
DW
Dieter Weinand
Chair of the Board of Directors
View full Anaveon profile